US 11660325
Compositions and methods of targeting cancer stem cells
granted A61KA61K31/357A61K31/381
Quick answer
US patent 11660325 (Compositions and methods of targeting cancer stem cells) held by The Board of Regents of the University of Texas System expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/357, A61K31/381, A61K38/04, A61K38/08